You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-Tumor Necrosis Factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biological Substance; Adverse Effect
  • Azithromycin Pill
  • Placebo
  • Haifa, Israel
    Rambam Health Care Campus
Oct 25, 2022

Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

Active, not recruiting
  • Colitis,Ulcerative
  • Discontinuation of anti-TNF treatment
  • Continuation of anti-TNF treatment
  • Alesund, Norway
  • +18 more
Jul 13, 2022

Ustekinumab in Active Crohn's Disease

Completed
  • Crohn Disease
  • Evaluation of biological predictive factors of clinical response to ustekinumab
  • Pierre-Bénite, France
    Centre hospitalier Lyon Sud
Aug 23, 2022

Rates of Dementia and Alzheimer's Disease in Participants

Completed
  • Dementia
  • Alzheimer Disease
  • Titusville, New Jersey
    Janssen R&D
Oct 15, 2021

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Anti-citrullinated Protein Antibody Status on Treatment Response

Completed
  • Rheumatoid Arthritis
  • Non-Interventional
  • Canberra City, Australia
    (unnamed)
Feb 22, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)

Withdrawn
  • Crohn Disease
  • Evansville, Indiana
    Medisphere Medical Research Center, Llc
Aug 30, 2021

Rheumatoid Arthritis Trial (ABT-494, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • (no location specified)
Jul 29, 2021

Diabetes, Type 1 Trial (Golimumab, Placebo)

Withdrawn
  • Diabetes Mellitus, Type 1
  • (no location specified)
Nov 19, 2021

Rheumatoid Arthritis Trial in Worldwide (ABX464 50mg, Matching Placebo, ABX464 100mg)

Completed
Has Results
  • Rheumatoid Arthritis
  • ABX464 50mg
  • +3 more
  • Bruxelles, Belgium
  • +23 more
Feb 3, 2022

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Rheumatoid Arthritis Trial in Leeuwarden (Filgotinib, Anti-Tumor Necrosis Factor Alpha Drug (Product), 50 patients will have a

Recruiting
  • Rheumatoid Arthritis
  • Leeuwarden, Netherlands
    Medical Center Leeuwarden MCL
Jul 30, 2021

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Cardiac Functions in Type 1 Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • transthoracic echocardiography
  • (no location specified)
Nov 12, 2023

Non-radiographic Spondyloarthritis Trial in Strasbourg (Education program)

Unknown status
  • Non-radiographic Spondyloarthritis
  • Education program
  • Strasbourg, France
    Hôpitaux Universitaires de Strasbourg
Oct 23, 2020

Pediatric Crohn's Disease Trial in United States (Methotrexate, Sugar pill ())

Completed
  • Pediatric Crohn's Disease
  • Birmingham, Alabama
  • +31 more
Jun 21, 2022

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • Inflammation
  • (no location specified)
Nov 21, 2023

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

Not yet recruiting
  • Pleural Effusion, Malignant
  • pleural markers
  • (no location specified)
Jan 20, 2023

Efficacy of Anti-TNF Therapy in AS: An Inception Cohort Study

Active, not recruiting
  • Ankylosing Spondylitis
  • Axial Spondyloarthritis
    • Adana, Turkey
    • +12 more
    Feb 16, 2021

    Rheumatoid Arthritis, Inflammatory Arthritis, Arthritis Trial in United States (Herpes Zoster (HZ) Vaccine, Placebo)

    Completed
    Has Results
    • Rheumatoid Arthritis
    • +7 more
    • Herpes Zoster (HZ) Vaccine
    • Placebo
    • Birmingham, Alabama
    • +33 more
    Oct 23, 2021

    Arthritis, Psoriatic Trial in Worldwide (Guselkumab 100 mg, Placebo)

    Completed
    • Arthritis, Psoriatic
    • Guselkumab 100 mg
    • Placebo
    • Brussels, Belgium
    • +116 more
    Nov 29, 2021

    Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier

    Completed
    • Arthritis Rheumatoid
    • New York, New York
      Pfizer
    Jun 8, 2022

    Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

    Recruiting
    • Hidradenitis Suppurativa
    • Lutikizumab
    • Placebo
    • Phoenix, Arizona
    • +54 more
    Jan 26, 2023